(GTLB) Gitlab - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US37637K1088
Stock: DevOps Platform, Software Development, Security Testing, Cloud Management
Total Rating 33
Risk 54
Buy Signal -1.08
| Risk 5d forecast | |
|---|---|
| Volatility | 57.9% |
| Relative Tail Risk | -11.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.24 |
| Alpha | -88.33 |
| Character TTM | |
|---|---|
| Beta | 1.708 |
| Beta Downside | 2.451 |
| Drawdowns 3y | |
|---|---|
| Max DD | 70.91% |
| CAGR/Max DD | -0.22 |
EPS (Earnings per Share)
Revenue
Risks
Technicals:
volatile
Description: GTLB Gitlab March 04, 2026
GitLab Inc. (GTLB) develops software for the entire software development lifecycle, known as DevSecOps. Its platform unifies stages from planning and source code management to security testing, deployment, and monitoring. This integrated approach is a key differentiator in the competitive enterprise software market.
The companys offerings enable organizations to manage and secure applications across diverse cloud environments. GitLab also provides training and professional services. This business model often involves recurring subscription revenue.
To deepen your understanding of GTLBs financial performance and market position, further research on platforms like ValueRay is recommended.
Headlines to watch out for
- DevSecOps platform adoption drives subscription revenue growth
- Cloud infrastructure spending impacts platform demand
- Cybersecurity spending trends influence enterprise sales
- Software development lifecycle efficiency boosts customer retention
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: -56.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 17.73 > 1.0 |
| NWC/Revenue: 105.1% < 20% (prev 104.2%; Δ 0.85% < -1%) |
| CFO/TA 0.14 > 3% & CFO 232.9m > Net Income -56.0m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 2.54 > 1.5 & < 3 |
| Outstanding Shares: last quarter (165.8m) vs 12m ago -2.52% < -2% |
| Gross Margin: 87.38% > 18% (prev 0.89%; Δ 8.65k% > 0.5%) |
| Asset Turnover: 61.19% > 50% (prev 54.26%; Δ 6.93% > 0%) |
| Interest Coverage Ratio: -3.33 > 6 (EBITDA TTM -57.4m / Interest Expense TTM -20.6m) |
Altman Z'' -0.65
| A: 0.58 (Total Current Assets 1.66b - Total Current Liabilities 652.1m) / Total Assets 1.72b |
| B: -0.71 (Retained Earnings -1.22b / Total Assets 1.72b) |
| C: -0.04 (EBIT TTM -68.7m / Avg Total Assets 1.56b) |
| D: -1.77 (Book Value of Equity -1.22b / Total Liabilities 686.5m) |
| Altman-Z'' Score: -0.65 = B |
Beneish M -3.25
| DSRI: 0.87 (Receivables 304.3m/278.5m, Revenue 955.2m/759.2m) |
| GMI: 1.02 (GM 87.38% / 88.79%) |
| AQI: 0.77 (AQ_t 0.03 / AQ_t-1 0.04) |
| SGI: 1.26 (Revenue 955.2m / 759.2m) |
| TATA: -0.17 (NI -56.0m - CFO 232.9m) / TA 1.72b) |
| Beneish M-Score: -3.25 (Cap -4..+1) = AA |
What is the price of GTLB shares?
As of March 18, 2026, the stock is trading at USD 22.88 with a total of 5,008,871 shares traded.
Over the past week, the price has changed by -1.34%, over one month by -19.49%, over three months by -39.58% and over the past year by -55.95%.
Over the past week, the price has changed by -1.34%, over one month by -19.49%, over three months by -39.58% and over the past year by -55.95%.
Is GTLB a buy, sell or hold?
Gitlab has received a consensus analysts rating of 4.54.
Therefore, it is recommended to buy GTLB.
- StrongBuy: 18
- Buy: 7
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the GTLB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 34.2 | 49.5% |
| Analysts Target Price | 34.2 | 49.5% |
GTLB Fundamental Data Overview March 17, 2026
P/E Forward = 28.0112
P/S = 4.0397
P/B = 3.8952
Revenue TTM = 955.2m USD
EBIT TTM = -68.7m USD
EBITDA TTM = -57.4m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = -229.6m USD (from netDebt column, last quarter)
Enterprise Value = 2.60b USD (3.86b + (null Debt) - CCE 1.26b)
Interest Coverage Ratio = -3.33 (Ebit TTM -68.7m / Interest Expense TTM -20.6m)
EV/FCF = 11.71x (Enterprise Value 2.60b / FCF TTM 222.0m)
FCF Yield = 8.54% (FCF TTM 222.0m / Enterprise Value 2.60b)
FCF Margin = 23.24% (FCF TTM 222.0m / Revenue TTM 955.2m)
Net Margin = -5.86% (Net Income TTM -56.0m / Revenue TTM 955.2m)
Gross Margin = 87.38% ((Revenue TTM 955.2m - Cost of Revenue TTM 120.6m) / Revenue TTM)
Gross Margin QoQ = 86.62% (prev 86.81%)
Tobins Q-Ratio = 1.51 (Enterprise Value 2.60b / Total Assets 1.72b)
Interest Expense / Debt = unknown (Interest Expense 7.25m / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = -54.3m (EBIT -68.7m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.54 (Total Current Assets 1.66b / Total Current Liabilities 652.1m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = 4.00 (negative EBITDA) (Net Debt -229.6m / EBITDA -57.4m)
Debt / FCF = -1.03 (Net Debt -229.6m / FCF TTM 222.0m)
Total Stockholder Equity = 897.1m (last 4 quarters mean from totalStockholderEquity)
RoA = -3.58% (Net Income -56.0m / Total Assets 1.72b)
RoE = -6.24% (Net Income TTM -56.0m / Total Stockholder Equity 897.1m)
RoCE = -6.42% (EBIT -68.7m / Capital Employed (Total Assets 1.72b - Current Liab 652.1m))
RoIC = -6.27% (negative operating profit) (NOPAT -54.3m / Invested Capital 865.8m)
WACC = 12.21% (E(3.86b)/V(3.86b) * Re(12.21%) + (debt-free company))
Discount Rate = 12.21% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.47%
[DCF] Terminal Value 53.91% ; FCFF base≈222.0m ; Y1≈145.7m ; Y5≈66.5m
[DCF] Fair Price = 6.50 (EV 766.4m - Net Debt -229.6m = Equity 996.0m / Shares 153.3m; r=12.21% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 71.99 | EPS CAGR: 83.43% | SUE: 1.13 | # QB: 1
Revenue Correlation: 99.01 | Revenue CAGR: 33.79% | SUE: 4.0 | # QB: 3
EPS next Quarter (2026-04-30): EPS=0.21 | Chg7d=+0.002 | Chg30d=+0.001 | Revisions Net=-4 | Analysts=26
EPS current Year (2027-01-31): EPS=0.79 | Chg7d=-0.240 | Chg30d=-0.242 | Revisions Net=-22 | Growth EPS=-17.9% | Growth Revenue=+16.6%
EPS next Year (2028-01-31): EPS=1.02 | Chg7d=-0.240 | Chg30d=-0.237 | Revisions Net=-17 | Growth EPS=+29.4% | Growth Revenue=+16.1%
[Analyst] Revisions Ratio: -0.22 (7 Up / 11 Down within 30d for Next Quarter)
P/S = 4.0397
P/B = 3.8952
Revenue TTM = 955.2m USD
EBIT TTM = -68.7m USD
EBITDA TTM = -57.4m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = -229.6m USD (from netDebt column, last quarter)
Enterprise Value = 2.60b USD (3.86b + (null Debt) - CCE 1.26b)
Interest Coverage Ratio = -3.33 (Ebit TTM -68.7m / Interest Expense TTM -20.6m)
EV/FCF = 11.71x (Enterprise Value 2.60b / FCF TTM 222.0m)
FCF Yield = 8.54% (FCF TTM 222.0m / Enterprise Value 2.60b)
FCF Margin = 23.24% (FCF TTM 222.0m / Revenue TTM 955.2m)
Net Margin = -5.86% (Net Income TTM -56.0m / Revenue TTM 955.2m)
Gross Margin = 87.38% ((Revenue TTM 955.2m - Cost of Revenue TTM 120.6m) / Revenue TTM)
Gross Margin QoQ = 86.62% (prev 86.81%)
Tobins Q-Ratio = 1.51 (Enterprise Value 2.60b / Total Assets 1.72b)
Interest Expense / Debt = unknown (Interest Expense 7.25m / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = -54.3m (EBIT -68.7m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.54 (Total Current Assets 1.66b / Total Current Liabilities 652.1m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = 4.00 (negative EBITDA) (Net Debt -229.6m / EBITDA -57.4m)
Debt / FCF = -1.03 (Net Debt -229.6m / FCF TTM 222.0m)
Total Stockholder Equity = 897.1m (last 4 quarters mean from totalStockholderEquity)
RoA = -3.58% (Net Income -56.0m / Total Assets 1.72b)
RoE = -6.24% (Net Income TTM -56.0m / Total Stockholder Equity 897.1m)
RoCE = -6.42% (EBIT -68.7m / Capital Employed (Total Assets 1.72b - Current Liab 652.1m))
RoIC = -6.27% (negative operating profit) (NOPAT -54.3m / Invested Capital 865.8m)
WACC = 12.21% (E(3.86b)/V(3.86b) * Re(12.21%) + (debt-free company))
Discount Rate = 12.21% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.47%
[DCF] Terminal Value 53.91% ; FCFF base≈222.0m ; Y1≈145.7m ; Y5≈66.5m
[DCF] Fair Price = 6.50 (EV 766.4m - Net Debt -229.6m = Equity 996.0m / Shares 153.3m; r=12.21% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 71.99 | EPS CAGR: 83.43% | SUE: 1.13 | # QB: 1
Revenue Correlation: 99.01 | Revenue CAGR: 33.79% | SUE: 4.0 | # QB: 3
EPS next Quarter (2026-04-30): EPS=0.21 | Chg7d=+0.002 | Chg30d=+0.001 | Revisions Net=-4 | Analysts=26
EPS current Year (2027-01-31): EPS=0.79 | Chg7d=-0.240 | Chg30d=-0.242 | Revisions Net=-22 | Growth EPS=-17.9% | Growth Revenue=+16.6%
EPS next Year (2028-01-31): EPS=1.02 | Chg7d=-0.240 | Chg30d=-0.237 | Revisions Net=-17 | Growth EPS=+29.4% | Growth Revenue=+16.1%
[Analyst] Revisions Ratio: -0.22 (7 Up / 11 Down within 30d for Next Quarter)